4-异喹啉硼酸 | 192182-56-2

• 物质功能分类: 化学试剂 - 有机试剂 - 硼酸
• 分子结构分类: 有机化合物 - 有机杂环化合物 - 异喹啉及其衍生物
• 中文名称: 4-异喹啉硼酸
• 中文别名: 异喹啉-4-硼酸
• 英文名称: 4-isoquinolineboronic acid
• 英文别名: isoquinolin-4-ylboronic acid；4-isoquinolinylboronic acid；isoquinoline-4-boronic acid；isoquinoline-4-ylboronic acid
• CAS: 192182-56-2
• 化学式: C₉H₈BNO₂
• 分子量: 172.979
• InChiKey: GDTOUTKTCGPAGY-UHFFFAOYSA-N

物化性质

• 熔点：
  178°C
• 沸点：
  419.1±37.0 °C(Predicted)
• 密度：
  1.28±0.1 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  -0.09
• 重原子数：
  13
• 可旋转键数：
  1
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  53.4
• 氢给体数：
  2
• 氢受体数：
  3

安全信息

• 危险等级：
  IRRITANT
• 危险品标志：
  Xi
• 安全说明：
  S26,S36/37/39
• 危险类别码：
  R36/37/38
• 海关编码：
  2933499090
• 危险类别：
  IRRITANT
• 危险标志：
  GHS07
• 危险性描述：
  H315,H319,H335
• 危险性防范说明：
  P261,P305 + P351 + P338
• 储存条件：
  2-8℃

SDS

---

Section 1. IDENTIFICATION OF THE SUBSTANCE/MIXTURE
Product name : 4-Isoquinolineboronic acid

---

Section 2. HAZARDS IDENTIFICATION
Classification of the substance or mixture
According to Regulation (EC) No1272/2008
Skin irritation (Category 2)
Eye irritation (Category 2)
Specific target organ toxicity - single exposure (Category 3)
According to European Directive 67/548/EEC as amended.
Irritating to eyes, respiratory system and skin.
Label elements
Pictogram
Signal word Warning
Hazard statement(s)
H315 Causes skin irritation.
H319 Causes serious eye irritation.
H335 May cause respiratory irritation.
Precautionary statement(s)
P261 Avoid breathing dust/ fume/ gas/ mist/ vapours/ spray.
P305 + P351 + P338 IF IN EYES: Rinse cautiously with water for several minutes. Remove
contact lenses, if present and easy to do. Continue rinsing.
Hazard symbol(s)
Xi Irritant
R-phrase(s)
R36/37/38 Irritating to eyes, respiratory system and skin.
S-phrase(s)
S26 In case of contact with eyes, rinse immediately with plenty of water and
seek medical advice.
Other hazards - none

---

Section 3. COMPOSITION/INFORMATION ON INGREDIENTS
Synonyms : Isoquinoline-4-boronic acid
Formula : C9H8BNO2
Molecular Weight : 172,98 g/mol
CAS-No. EC-No. Index-No. Classification Concentration
4-Isoquinoline boronic acid
192182-56-2 - - Skin Irrit. 2; Eye Irrit. 2; STOT -
SE 3; H315, H319, H335
Xi, R36/37/38
For the full text of the H-Statements mentioned in this Section, see Section 16.

---

Section 4. FIRST AID MEASURES
General advice
Consult a physician. Show this safety data sheet to the doctor in attendance.
If inhaled
If breathed in, move person into fresh air. If not breathing, give artificial respiration. Consult a physician.
In case of skin contact
Wash off with soap and plenty of water. Consult a physician.
In case of eye contact
Rinse thoroughly with plenty of water for at least 15 minutes and consult a physician.
If swallowed
Never give anything by mouth to an unconscious person. Rinse mouth with water. Consult a physician.

---

Section 5. FIRE-FIGHTING MEASURES
Suitable extinguishing media
Use water spray, alcohol-resistant foam, dry chemical or carbon dioxide.
Special protective equipment for fire-fighters
Wear self contained breathing apparatus for fire fighting if necessary.

---

Section 6. ACCIDENTAL RELEASE MEASURES
Personal precautions
Use personal protective equipment. Avoid dust formation. Avoid breathing vapors, mist or gas. Ensure
adequate ventilation. Evacuate personnel to safe areas. Avoid breathing dust.
Environmental precautions
Do not let product enter drains.
Methods and materials for containment and cleaning up
Pick up and arrange disposal without creating dust. Sweep up and shovel. Keep in suitable, closed
containers for disposal.

---

Section 7. HANDLING AND STORAGE
Precautions for safe handling
Avoid contact with skin and eyes. Avoid formation of dust and aerosols.
Provide appropriate exhaust ventilation at places where dust is formed. Normal measures for preventive fire
protection.
Conditions for safe storage
Keep container tightly closed in a dry and well-ventilated place.
Recommended storage temperature: 2 - 8 °C

---

Section 8. EXPOSURE CONTROLS/PERSONAL PROTECTION
Personal protective equipment
Respiratory protection
For nuisance exposures use type P95 (US) or type P1 (EU EN 143) particle respirator.For higher level
protection use type OV/AG/P99 (US) or type ABEK-P2 (EU EN 143) respirator cartridges. Use respirators
and components tested and approved under appropriate government standards such as NIOSH (US) or
CEN (EU).
Hand protection
Handle with gloves. Gloves must be inspected prior to use. Use proper glove removal technique (without
touching glove's outer surface) to avoid skin contact with this product. Dispose of contaminated gloves
after use in accordance with applicable laws and good laboratory practices. Wash and dry hands.
The selected protective gloves have to satisfy the specifications of EU Directive 89/686/EEC and the
standard EN 374 derived from it.
Eye protection
Safety glasses with side-shields conforming to EN166 Use equipment for eye protection tested and
approved under appropriate government standards such as NIOSH (US) or EN 166(EU).
Skin and body protection
impervious clothing, The type of protective equipment must be selected according to the concentration
and amount of the dangerous substance at the specific workplace.
Hygiene measures
Handle in accordance with good industrial hygiene and safety practice. Wash hands before breaks and at
the end of workday.

---

Section 9. PHYSICAL AND CHEMICAL PROPERTIES
Appearance
Form solid
Safety data
pH no data available
Melting point 230 - 234 °C
Boiling point no data available
Flash point no data available
Ignition temperature no data available
Lower explosion limit no data available
Upper explosion limit no data available
Water solubility no data available
Partition coefficient: log Pow: 1,615
n-octanol/water

---

Section 10. STABILITY AND REACTIVITY
Chemical stability
Stable under recommended storage conditions.
Conditions to avoid
no data available
Materials to avoid
Strong oxidizing agents
Hazardous decomposition products
Hazardous decomposition products formed under fire conditions. - Carbon oxides, nitrogen oxides (NOx),
Borane/boron oxides

---

Section 11. TOXICOLOGICAL INFORMATION
Acute toxicity
no data available
Skin corrosion/irritation
no data available
Serious eye damage/eye irritation
no data available
Respiratory or skin sensitization
no data available
Germ cell mutagenicity
no data available
Carcinogenicity
IARC: No component of this product present at levels greater than or equal to 0.1% is identified as
probable, possible or confirmed human carcinogen by IARC.
Reproductive toxicity
no data available
Specific target organ toxicity - single exposure
Inhalation - May cause respiratory irritation.
Specific target organ toxicity - repeated exposure
no data available
Aspiration hazard
no data available
Potential health effects
Inhalation May be harmful if inhaled. Causes respiratory tract irritation.
Ingestion May be harmful if swallowed.
Skin May be harmful if absorbed through skin. Causes skin irritation.
Eyes Causes serious eye irritation.
Signs and Symptoms of Exposure
To the best of our knowledge, the chemical, physical, and toxicological properties have not been thoroughly
investigated.
Additional Information
RTECS: Not available

---

Section 12. ECOLOGICAL INFORMATION
Toxicity
no data available
Persistence and degradability
no data available
Bioaccumulative potential
no data available
Mobility in soil
no data available
PBT and vPvB assessment
no data available
Other adverse effects
no data available

---

Section 13. DISPOSAL CONSIDERATIONS
Product
Offer surplus and non-recyclable solutions to a licensed disposal company. Contact a licensed professional
waste disposal service to dispose of this material. Dissolve or mix the material with a combustible solvent
and burn in a chemical incinerator equipped with an afterburner and scrubber.
Contaminated packaging
Dispose of as unused product.

---

Section 14. TRANSPORT INFORMATION
ADR/RID
Not dangerous goods
IMDG
Not dangerous goods
IATA
Not dangerous goods

---

Section 15. REGULATORY INFORMATION
This safety datasheet complies with the requirements of Regulation (EC) No. 1907/2006.

---

Section 16. OTHER INFORMATION
Text of H-code(s) and R-phrase(s) mentioned in Section 3
Eye Irrit. Eye irritation
H315 Causes skin irritation.
H319 Causes serious eye irritation.
H335 May cause respiratory irritation.
Skin Irrit. Skin irritation
STOT SE Specific target organ toxicity - single exposure
Xi Irritant
R36/37/38 Irritating to eyes, respiratory system and skin.
Further information
Copyright 2010 Co. License granted to make unlimited paper copies for internal use only.
The above information is believed to be correct but does not purport to be all inclusive and shall be used
only as a guide. The information in this document is based on the present state of our knowledge and is
applicable to the product with regard to appropriate safety precautions. It does not represent any guarantee
of the properties of the product. Co., shall not be held liable for any damage resulting from
handling or from contact with the above product. See reverse side of invoice or packing slip for additional
terms and conditions of sale.

反应信息

• 作为反应物：
  描述：

  4-异喹啉硼酸 在 bismuth (III) nitrate pentahydrate 作用下， 以 苯 为溶剂， 反应 2.0h， 以68%的产率得到4-硝基异喹啉
  参考文献：
  名称：

  催化剂-自由本位的芳基硼酸使用硝酸铋-nitration

  摘要：

  我们报告的催化剂-自由本位使用铋的芳基硼酸-nitration（III）硝酸盐作为硝化剂。反应以较短的反应时间进行，具有中等至极好的收率。该方法操作简单，区域选择性好，并且具有出色的官能团相容性，可以合成硝基芳烃。

  DOI：

  10.1016/j.tetlet.2012.08.121
• 作为产物：
  描述：

  在 sodium hydroxide 作用下， 以 四氢呋喃 、 水 为溶剂， 反应 2.0h， 以96%的产率得到4-异喹啉硼酸
  参考文献：
  名称：

  异喹啉衍生的二硼酸盐对差向异构单糖的显着发散荧光响应

  摘要：

  在这里，我们报告了一种基于 4-异喹啉硼酸的新型硼酸荧光传感器，该传感器具有荧光发散响应与生物学相关的单糖、葡萄糖和半乳糖。通过分析这种传感器与几种替代糖形式的相互作用，我们能够确定硼酸如何选择二醇进行结合，以及这种分子如何对两种非常相似的己糖产生正负荧光响应。

  DOI：

  10.1016/j.tetlet.2022.153698

文献信息

• Fluorescent Probes from Aromatic Polycyclic Nitrile Oxides: Isoxazoles versus Dihydro‐1λ ³ ,3,2λ ⁴ ‐Oxazaborinines
  作者：Mattia Moiola、Antonio Bova、Stefano Crespi、Misal G. Memeo、Mariella Mella、Herman S. Overkleeft、Bogdan I. Florea、Paolo Quadrelli

  DOI：10.1002/open.201900137

  日期：2019.6

  elaborated and functionalized with a protected triple bond. The introduction of a bromine atom at the position C10 of the anthracene moiety allows for inserting a variety of aromatic and heterocyclic substituents through Suzuki coupling. A two‐way synthetic route can lead to simple isoxazole derivatives or, after N−O bond reductive cleavage and BF3 complexation, enamino ketone boron complexes. The

  蒽腈与炔丙基溴进行1,3-偶极环加成反应，得到预期的异恶唑，为单一的区域异构体，可以通过合成方法合成并用受保护的三键官能化。在蒽部分的位置C10处引入溴原子允许通过Suzuki偶联插入各种芳族和杂环取代基。双向合成途径可导致简单的异恶唑衍生物，或在N-O键还原裂解和BF 3之后络合，烯氨基酮硼配合物。研究了取代的异恶唑和相应的硼配合物的光物理性质，以显示在成像技术中用作荧光标记的潜力。相当好的量子产率值证实了这些化合物在细胞环境中的适用性。讨论了该方法的范围和局限性。
• [EN] PYRAZOLOPYRIDINE DERIVATIVES FOR THE TREATMENT OF CANCER<br/>[FR] DÉRIVÉS DE PYRAZOLOPYRIDINE POUR LE TRAITEMENT DU CANCER
  申请人：GENENTECH INC

  公开号：WO2017205538A1

  公开（公告）日：2017-11-30

  The present invention relates to a compound formula (I): and to salts thereof, wherein R1, R2X, and Y have any of the values defined herein, and compositions and uses thereof. The compounds are useful as inhibitors of CBP and/or EP300. Also included are pharmaceutical compositions comprising a compound of formula (I) or a pharmaceutically acceptable salt thereof, and methods of using such compounds and salts in the treatment of various CBP and/or EP300-mediated disorders such as cancer, inflammatory disorders and autoimmune diseases.

  本发明涉及一种化合物公式（I）及其盐，其中R1、R2X和Y具有本文中定义的任何值，以及其组合物和用途。这些化合物可用作CBP和/或EP300的抑制剂。还包括包含公式（I）化合物或其药学上可接受的盐的药物组合物，以及在治疗各种CBP和/或EP300介导的疾病，如癌症、炎症性疾病和自身免疫疾病中使用这些化合物和盐的方法。
• Design, synthesis, and electrophysiological evaluation of NS6740 derivatives: Exploration of the structure-activity relationship for alpha7 nicotinic acetylcholine receptor silent activation
  作者：Maria Chiara Pismataro、Nicole A. Horenstein、Clare Stokes、Marta Quadri、Marco De Amici、Roger L. Papke、Clelia Dallanoce

  DOI：10.1016/j.ejmech.2020.112669

  日期：2020.11

  The α7 nicotinic acetylcholine receptor (nAChR) silent agonists, able to induce receptor desensitization and promote the α7 metabotropic function, are emerging as new promising therapeutic anti-inflammatory agents. Herein, we report the structure–activity relationship investigation of the archetypal silent agonist NS6740 (1,4-diazabicyclo[3.2.2]nonan-4-yl(5-(3-(trifluoromethyl)-phenyl)-furan-2-yl)methanone)

  能够诱导受体脱敏并促进α7代谢功能的α7烟碱型乙酰胆碱受体（nAChR）沉默激动剂，正在成为新兴的新型治疗性抗炎药。在这里，我们报告原型沉默激动剂NS6740（1,4-二氮杂双环[3.2.2]壬南-4-基（5-（3-（三氟甲基）-苯基）-呋喃-2-基）的结构-活性关系研究）（甲酮）（1）阐明负责α7沉默激活的配体-受体相互作用。在这项研究中，NS6740片段11 - 16和类似物17 - 32设计，合成，并测定对表达的人α7烟碱受体爪蟾两电极电压钳制实验的卵母细胞。NS6740的所有结构部分对于产生其独特的活性谱至关重要。二氮杂双环核是必需的，但不足以诱导α7沉默激活。中央氢键受体核和芳族部分对于促进延长的α7受体结合和持续的脱敏至关重要。化合物13和17是有效的部分激动剂。化合物12，21，23 - 26，和30α7nAChR高度脱敏，因此可能对炎症反应的其他研究感兴趣。我们获得了有助于进一步沉默激动剂发展的关键结构信息。
• Optimization of the First Selective Steroid-11β-hydroxylase (CYP11B1) Inhibitors for the Treatment of Cortisol Dependent Diseases
  作者：Ulrike E. Hille、Christina Zimmer、Jörg Haupenthal、Rolf W. Hartmann

  DOI：10.1021/ml100283h

  日期：2011.8.11

  CYP11B1 is the key enzyme in cortisol biosynthesis, and its inhibition with selective compounds is a promising strategy for the treatment of diseases associated with elevated cortisol levels, such as Cushing’s syndrome or metabolic disease. Expanding on a previous study from our group resulting in the first potent and rather selective inhibitor described so far (1, IC50 = 152 nM), we herein describe

  CYP11B1 是皮质醇生物合成的关键酶，它用选择性化合物抑制是治疗与皮质醇水平升高相关的疾病（如库欣综合征或代谢疾病）的有前景的策略。Expanding on a previous study from our group resulting in the first potent and rather selective inhibitor described so far ( 1 , IC 50 = 152 nM), we herein describe further optimizations of the imidazolylmethyl pyridine core. 合成的 42 种物质中有五种化合物的 IC 50值低于 50 nM。最有趣的是naphth-1-yl 化合物23 (IC 50 = 42 nM)，对高度同源的CYP11B2 ( 1：18 倍）以及分别对雄激素和雌激素形成酶
• Cu-Catalyzed Cyanation of Arylboronic Acids with Acetonitrile: A Dual Role of TEMPO
  作者：Yamin Zhu、Linyi Li、Zengming Shen

  DOI：10.1002/chem.201501823

  日期：2015.9.14

  acetonitrile as the “CN” source has been achieved under a Cu(cat.)/TEMPO system (TEMPO=2,2,6,6‐tetramethylpiperidine N‐oxide). The broad substrate scope includes a variety of electron‐rich and electron‐poor arylboronic acids, which react well to give the cyanated products in high to excellent yields. Mechanistic studies reveal that TEMPOCH2CN, generated in situ, is an active cyanating reagent, and shows high

  在Cu（cat。）/ TEMPO系统（TEMPO = 2,2,6,6-四甲基哌啶N-氧化物）下，通过使用乙腈作为“ CN”源实现了芳基硼酸的氰化。广泛的底物范围包括各种富电子和贫电子的芳基硼酸，它们能很好地反应，从而以高收率或优异的收率得到氰化产物。机制研究揭示，TEMPO  CH 2 CN，在原位产生，是有源氰化试剂，并示出了对于CN的形成高反应性-部分。而且，TEMPO充当廉价的氧化剂，使反应能够在铜中催化。